MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $48,816,687 | +23.2% | 2,032,335 | 0.0% | 1.09% | +32.7% |
Q4 2022 | $39,630,533 | -7.2% | 2,032,335 | 0.0% | 0.82% | -3.5% |
Q3 2022 | $42,699,000 | -32.4% | 2,032,335 | -37.4% | 0.85% | -34.7% |
Q2 2022 | $63,137,000 | -12.7% | 3,244,434 | -1.2% | 1.30% | -19.4% |
Q1 2022 | $72,290,000 | +38.1% | 3,282,912 | 0.0% | 1.62% | +47.2% |
Q4 2021 | $52,362,000 | -19.9% | 3,282,912 | 0.0% | 1.10% | -13.9% |
Q3 2021 | $65,396,000 | +9.7% | 3,282,912 | -4.8% | 1.28% | +20.5% |
Q2 2021 | $59,632,000 | -12.8% | 3,448,912 | 0.0% | 1.06% | -26.3% |
Q1 2021 | $68,357,000 | +13.5% | 3,448,912 | 0.0% | 1.44% | +20.8% |
Q4 2020 | $60,218,000 | -9.4% | 3,448,912 | 0.0% | 1.19% | -26.5% |
Q3 2020 | $66,461,000 | -1.0% | 3,448,912 | 0.0% | 1.62% | -17.2% |
Q2 2020 | $67,116,000 | +39.0% | 3,448,912 | 0.0% | 1.96% | +27.6% |
Q1 2020 | $48,285,000 | -42.9% | 3,448,912 | 0.0% | 1.53% | -43.2% |
Q4 2019 | $84,567,000 | +143.7% | 3,448,912 | 0.0% | 2.70% | +90.7% |
Q3 2019 | $34,696,000 | – | 3,448,912 | – | 1.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |